Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6431573rdf:typepubmed:Citationlld:pubmed
pubmed-article:6431573lifeskim:mentionsumls-concept:C0042960lld:lifeskim
pubmed-article:6431573lifeskim:mentionsumls-concept:C1549078lld:lifeskim
pubmed-article:6431573lifeskim:mentionsumls-concept:C1997894lld:lifeskim
pubmed-article:6431573lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:6431573lifeskim:mentionsumls-concept:C0035203lld:lifeskim
pubmed-article:6431573lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6431573lifeskim:mentionsumls-concept:C0020591lld:lifeskim
pubmed-article:6431573lifeskim:mentionsumls-concept:C0054151lld:lifeskim
pubmed-article:6431573pubmed:issue3lld:pubmed
pubmed-article:6431573pubmed:dateCreated1984-9-20lld:pubmed
pubmed-article:6431573pubmed:abstractTextIn a double-blind, cross-over study we measured the effect of a 0.5-mg oral dose of brotizolam, a new thienodiazepine hypnotic, on cardiac and respiratory functions in 12 healthy volunteers. No deleterious effects on pulse, blood pressure, forced vital capacity, forced expiratory volume in 1 s, respiratory rate, mouth occlusion pressure (P0.1) and ventilatory responses to carbon dioxide occurred over a 6-hour period. In the usual therapeutic dose, brotizolam does not suppress cardiac and respiratory functions in healthy volunteers.lld:pubmed
pubmed-article:6431573pubmed:languageenglld:pubmed
pubmed-article:6431573pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6431573pubmed:citationSubsetIMlld:pubmed
pubmed-article:6431573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6431573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6431573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6431573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6431573pubmed:statusMEDLINElld:pubmed
pubmed-article:6431573pubmed:issn0025-7931lld:pubmed
pubmed-article:6431573pubmed:authorpubmed-author:CohnM AMAlld:pubmed
pubmed-article:6431573pubmed:issnTypePrintlld:pubmed
pubmed-article:6431573pubmed:volume45lld:pubmed
pubmed-article:6431573pubmed:ownerNLMlld:pubmed
pubmed-article:6431573pubmed:authorsCompleteYlld:pubmed
pubmed-article:6431573pubmed:pagination281-5lld:pubmed
pubmed-article:6431573pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:6431573pubmed:meshHeadingpubmed-meshheading:6431573-...lld:pubmed
pubmed-article:6431573pubmed:meshHeadingpubmed-meshheading:6431573-...lld:pubmed
pubmed-article:6431573pubmed:meshHeadingpubmed-meshheading:6431573-...lld:pubmed
pubmed-article:6431573pubmed:meshHeadingpubmed-meshheading:6431573-...lld:pubmed
pubmed-article:6431573pubmed:meshHeadingpubmed-meshheading:6431573-...lld:pubmed
pubmed-article:6431573pubmed:meshHeadingpubmed-meshheading:6431573-...lld:pubmed
pubmed-article:6431573pubmed:meshHeadingpubmed-meshheading:6431573-...lld:pubmed
pubmed-article:6431573pubmed:meshHeadingpubmed-meshheading:6431573-...lld:pubmed
pubmed-article:6431573pubmed:meshHeadingpubmed-meshheading:6431573-...lld:pubmed
pubmed-article:6431573pubmed:meshHeadingpubmed-meshheading:6431573-...lld:pubmed
pubmed-article:6431573pubmed:meshHeadingpubmed-meshheading:6431573-...lld:pubmed
pubmed-article:6431573pubmed:meshHeadingpubmed-meshheading:6431573-...lld:pubmed
pubmed-article:6431573pubmed:meshHeadingpubmed-meshheading:6431573-...lld:pubmed
pubmed-article:6431573pubmed:year1984lld:pubmed
pubmed-article:6431573pubmed:articleTitleThe effects of brotizolam, a new hypnotic, on cardiac and respiratory function in volunteers.lld:pubmed
pubmed-article:6431573pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6431573pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:6431573pubmed:publicationTypeControlled Clinical Triallld:pubmed
pubmed-article:6431573pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed